Yukio Kondo
Overview
Explore the profile of Yukio Kondo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagafuji K, Ito Y, Miyamoto T, Eto T, Kamimura T, Kato K, et al.
Eur J Haematol
. 2025 Mar;
PMID: 40052397
Aim: To assess the efficacy of continuous dasatinib in improving outcomes for adult patients with BCR::ABL1 ALL. Methods: The prospective, multicenter ALL/MRD2014 trial introduced a modified protocol compared to the...
2.
Shimada K, Yamaguchi M, Kuwatsuka Y, Matsue K, Sato K, Kusumoto S, et al.
EClinicalMedicine
. 2025 Feb;
80:103078.
PMID: 39968389
Background: Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal large B-cell lymphoma for which prognosis is typically poor without a timely diagnosis. To explore the safety and...
3.
Iwasaki M, Kanda J, Tanaka H, Ikegame K, Shindo T, Kawase T, et al.
Transplantation
. 2025 Feb;
PMID: 39948727
Background: The introduction of posttransplant cyclophosphamide (PTCy) for prophylaxis against graft-versus-host disease (GVHD) has led to an increase in the number of transplants from haploidentical donors. Accordingly, we aimed to...
4.
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, et al.
Glob Health Med
. 2024 Sep;
6(4):277-281.
PMID: 39219588
This study aimed to establish a standard treatment for disseminated extranodal large B-cell lymphoma, including intravascular large B-cell lymphoma (DEN-LBCL/IVL), and to validate the clinical diagnostic criteria we proposed. Between...
5.
Fukunaga K, Ikegame K, Nakamae H, Doki N, Fukuda T, Kondo Y, et al.
Int J Hematol
. 2024 Jan;
119(2):173-182.
PMID: 38233701
In HLA haploidentical stem cell transplantation, patients and donors usually share one HLA haplotype and have one different HLA haplotype (hetero-to-hetero). However, there are rare cases of transplantation from HLA...
6.
Naoe T, Saito A, Hosono N, Kasahara S, Muto H, Hatano K, et al.
Cancer Immunol Immunother
. 2023 Apr;
72(8):2865-2871.
PMID: 37093243
We previously conducted a randomized phase II trial of OCV-501, a WT1 peptide presented by helper T cells, in elderly AML (acute myeloid leukemia) patients in first remission, indicating no...
7.
Yanada M, Matsuda K, Ishii H, Fukuda T, Ozeki K, Ota S, et al.
Transplant Cell Ther
. 2022 Sep;
28(12):847.e1-847.e8.
PMID: 36179987
Although autologous hematopoietic cell transplantation (HCT) is an established therapy for patients with relapsed acute promyelocytic leukemia (APL) after returning to complete remission (CR), the role of allogeneic HCT remains...
8.
Ishiyama K, Sato K, Imi T, Hosokawa K, Kondo Y, Sugimori N, et al.
EJHaem
. 2022 Jul;
1(1):243-248.
PMID: 35847715
To identify factors affecting responsiveness to eltrombopag (EPAG), we retrospectively analyzed 38 aplastic anemia patients treated with EPAG who were refractory (n = 29) or showed an inadequate response (n ...
9.
Yamada S, Arita K, Kondo Y, Mizuta S, Okumura H
Case Rep Oncol
. 2022 Jul;
15(2):535-540.
PMID: 35813699
Chronic myeloid leukemia (CML) blast phase (monocytic lineage) is extremely rare. A 39-year-old Japanese man was diagnosed with CML blast phase (monocytic lineage). T315I mutation was positive, ponatinib was initially...
10.
Nakagawa N, Yamano R, Kajikawa S, Kondo Y, Okumura H
Leuk Res Rep
. 2022 Jun;
17:100331.
PMID: 35669930
The optimal therapy for relapsed primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS) remains unclear. We herein report a case of relapsed primary DLBCL of the...